199 | PEMBROLIZUMAB THERAPY INDUCES AN INFLAMMATORY RESPONSE IN LYMPHOMA PATIENTS BY RESHAPING MONOCYTES RESULTING IN HYPERPROGRESSIVE DISEASE
Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available
10.1002/hon.70094_199